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Abstract 
 
Background:  To find out the effectiveness of ketorolac 
administered at the end of surgery in reducing pain scores 
and the length of stay in the Post Anaesthetic Care Unit 
(PACU) for the patients undergoing major abdominal 
surgery. 
 
Methods:  This interventional study, a double blind 
randomized control trial was conducted at POF Hospital, 
Wah Cantt, over a three year period starting 2004.  One 
hundred adult patients, planned for major surgery 
fulfilling the inclusion criteria were randomized by simple 
random numbers table into two groups by codes. At the 
end of procedure, 30mg ketorolac (an NSAID) was given 
intravenously to every member of ketorolac group and 10 
ml normal saline I/V (placebo) was given to every member 
in control group.  All the patients were shifted  
to PACU.  The doctor in charge PACU had to decide the 
length of stay based on two parameters; 1) Pain score on 
the basis of visual analogue score (VAS) and 2) Salim ABC 
score for recovery room stay. 
 
Results:  The initial mean post operative scores in the 
PACU were lower for ketorolac group, 3.6 on Visual 
analogue score(VAS) with a standard deviation (S.D.)  
of +/-0.9, and for control group the respective mean 
postoperative pain score was 5.4 with the S.D. of +/-1.3. 
This difference was of statistical significance with a  
p value of less than 0.05.  The mean length of stay  
in PACU for ketorolac group was 97 minutes with an  
S.D. of +/-30 minutes, while the corresponding mean  
and S.D. for the control group were 134 minutes  
and +/-35 minutes respectively which also depicted  
a difference of statistical significance with a p value of  
less than 0.05. 
 
Conclusion:  Ketorolac administered I/V at the end of 
surgery effectively controls the immediate post operative 
pain and reduces the length of stay in PACU. 
 
 
Introduction 
 
Recovery is the period of cessation of the 
administration of anaesthesia until the patient is 
awake with good protective reflexes.  It is a re-
equilibration of the body with atmospheric air and  
its speed depends upon many factors like period  
of surgery and anaesthetics administered.  Adequate 
management of postoperative pain is important for  
the reasons that it affects the physiological, emotional 
and psychological outcome of the patient. 
Postoperative analgesia can be obtained by 
different medications including nonsteroidal anti-
inflammatory drugs (NSAIDS), opioids, regional and 
local anaesthetic techniques1.  Adverse outcome of 
patient may also be associated with therapeutic 
modalities e.g. opioids leading to undesired effects  
like sedation, vomiting, respiratory or circulatory 
depression. 
Effectiveness and safety of ketorolac, an 
NSAID, has been proved in various clinical settings  
of postoperative pain. Having seen the claims of 
effectiveness of ketorolac in controlling the pain, this 
study was carried out with the intent to validate the 
usefulness of ketorolac in pain control in postoperative 
period and also to measure its effect on length of stay 
in PACU2. 
 
Patients and Methods 
 
For this experimental study, the ethical 
committee approval was obtained.  One hundred 
patients were selected who had to undergo major 
abdominal surgery and fulfilled the inclusion criteria. 
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Informed consent was obtained from all patients.  
Inclusion criteria comprised male or female patients 
between 30 and 60 years of age who consented at  
free will and fulfilled the criteria of American Society 
of Anaesthesiology (ASA) grade-I or ASA grade II 
patients. 
Exclusion criteria comprised history of 
gastrointestinal bleeding, allergy to NSAIDs, presence 
of a bleeding disorder and renal insufficiency.   
Also excluded were patients with morbid obesity, 
pregnancy and jaundice.  Patients with history of 
asthma or chronic obstructive pulmonary disease  
and patients with ASA grade III or IV were also 
excluded. 
Investigations done in all patients were  
blood CP and urinalysis, bleeding and clotting time, 
liver function tests (LFTs) and serum urea and 
creatinine. 
Selected patients were then randomized 
through simple random numbers table in two groups 
named ketorolac group and control group.  Ketorolac 
group were to receive an intravenous (I/V) bolus  
dose of 30mg ketorolac (Toradol brand by Roche) 
diluted in 10ml normal saline.  The control group 
received 10ml of normal saline as placebo at the  
time of first skin stitch at the end of procedure  
by the in charge anaesthetist in the operation room 
who was blinded to randomization.  Every patient  
in both the groups underwent major abdominal 
surgery through a standard midline incision and  
layer wise closure of the abdomen using the  
same suture material and technique.  All patients  
had general anaesthesia with morphine (0.1mg/  
kg) I/V and propofol (2.5mg/kg) I/V.  Tracheal 
intubation was performed using rocronium bromide 
(0.45 mg/kg)  Anaesthesia was maintained on oxygen, 
nitrous oxide and halothane until last skin stitch.   
All patients were extubated after reversal of paralysis 
and shifted to post anaesthetic care unit (PACU) or 
recovery room. 
The in charge PACU who was also blinded  
to the randomization had to monitor the pain scores 
and to decide the length of the stay of the patient in 
the PACU. 
The pain was assessed with the help of Visual 
analogue score (VAS) (Table 1), the interpretation of 
which was thoroughly explained to the patients before 
undergoing surgery. 
The length of stay in PACU was decided  
on two criteria, the pain score and the Salim ABC  
score (Table 2).  A pain score of less than 4 along  
with a Salim ABC score of 8 or more formed the 
criteria of discharge from PACU.  If the pain score  
was more than 4 rescue analgesia was offered in the 
form of injection morphine (0.1 mg/kg).  Physiological 
parameters were continuously monitored and 
included pulse, blood pressure, respiratory rate (RR) 
and oxygen saturation (SaO2) for the patients in  
both the groups.  Bleeding time, clotting time, blood 
urea and serum creatinine of every member in the 
study were serially monitored.  Chi-square test was 
employed to draw statistical inference. 
 
Table 1:  Visual Analogue Scale 
 
0 1 2 3 4 5 6 7 8 9 10 
No pain Mild pain Moderate pain Severe pain Very severe pain Worst pain 
 
Table 2:  Salim ABC Score for Recovery Room 
 
Scores 3 2 1 0 
Airways Can cough or cry Maintain airway 
without holding jaw 
Jaw holding needed Measures other than 
jaw holding needed 
Behaviour Can lift head Can open eyes and 
show tongue 
Some non-purposeful 
movements 
No movements at all 
Consciousness Fully awake, can Awake but needs Responds to stimuli only No response 
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talk and oriented support 
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Table 3:  Pain Scores and PACU Stay 
 
Groups No. of patients Pain score PACU stay in minutes (min) 
Ketorolac 50 2.7-4.5 (average 3.6) 67-127 minutes (average 97) 
Control 50 4.1-6.7 (average 5.4) 99-169 minutes (average 134) 
 
Results 
 
The mean for the initial postoperative  
pain scores for the ketorolac group was 3.6 with  
an S.D. of +/-0.9 and for the control group the mean 
was 5.4 with an S.D. of +/- 1.3 in the PACU.  It was  
a statistically significant difference with a p value of 
less than 0.05.  The length of stay in the PACU for  
the ketorolac group had a mean of 97 minutes with an 
S.D. of +/- 35 minutes and this was also statistically 
significant difference with a p value of less than 0.05.  
Results are summarized in Table 3. 
No significant difference in the physiological 
parameters (pulse, BP, RR and oxygen saturation)  
was observed between both groups.  There was no 
significant alteration of renal parameters, LFTs or 
bleeding and clotting times.  There was also no 
significant evidence of nausea and vomiting in  
both the groups.  Three patients were withdrawn  
from the study:  two for prolonged surgery because  
of malignant disease and another for postoperative 
adhesions. 
 
Discussion 
 
Resumption of protective reflexes, cognitive 
functions and control of postoperative pain is one of 
the major concerns in PACU after surgery.  Other 
concerns include control of post operative nausea  
and vomiting, oxygenation, breathing and bleeding 
from site of operation.  The intensity of postoperative 
pain varies with the individual patient and largely 
depends upon the site and nature of operation  
and constitution of the patient4.  The acute surgical 
pain after upper abdominal surgery is more severe 
than after lower abdominal surgery. Postoperative 
pain differs from other types of pains in that it is 
usually transitory; with a progressive improvement 
over a relatively short time course5.  Furthermore 
acute pain is more easily amenable to therapy than 
chronic pain. 
One area of managing immediate post-
operative pain is to manage it before return to 
consciousness for the reason that the dose of an 
analgesic required to prevent pain is only a fraction  
of that required to control it once it has become  
severe.  Moreover, the early administration of a  
strong analgesic is a useful method of decreasing 
postoperative pain and to modify the systemic 
response of the patient to acute pain6. 
In one randomized clinical trial effectiveness 
and safety of ketorolac (an NSAID) was compared 
with that of morphine (an opioid) in controlling 
postoperative pain in cases of upper abdominal 
surgery and it was found that Ketorolac had a clear 
morphine sparing effect7.  In yet another clinical trial it 
was concluded that 30mg of Ketorolac given I/V 
provides analgesia equivalent to 6-12 mg of morphine 
given by the same route with the similar onset of 
action but longer duration (6-8 hours)8. 
In a similar clinical trial it was established that 
morphine given immediately before the end of surgery 
proved effective in controlling postoperative pain 
scores in PACU9.  It also has another advantage of 
reduced subsequent analgesic requirement. 
In our study, ketorolac group depicted the 
significant reduction in pain score i.e., an average of 
3.6 on VAS (mild pain) against placebo group with 
pain score of 5.4 (moderate pain). Similarly, the 
duration of stay was also significantly reduced i.e.,  
97 minutes average stay in control group against  
134 minutes average stay in the placebo group.  The 
patients were better conversant in ketorolac group 
than the other group and were psychosomatically 
better with better sensorium than the control group. 
Many problems associated with anaesthesia 
and surgery may occur in immediate postoperative 
period.  It is essential to continue supervision of the 
patient by experienced personnel during recovery.   
It is usually desired that the patient resume protective 
reflexes and consciousness at the earliest as this period 
may last from several minutes to few hours.  Opioids 
may also reduce the postoperative stay in PACU but 
ketorolac does the same with lesser degree of 
undesired effects of opioids. 
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Conclusion 
 
Ketorolac (30mg) intravenous, administered at 
the end of surgery is an effective method of controlling 
immediate postoperative and pain reduces length of 
stay in post anaesthesia care unit. 
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